Korean J Med.
2007 Feb;72(2):237-241.
Clinical evaluation of hemochromatosis with end-stage renal disease
- Affiliations
-
- 1Department of Internal Medicine, Inje University College of Medicine, Sanggaepaik Hospital, Seoul, Korea. Wondoful1958@naver.com
Abstract
- Hemochromatosis is almost always a consequence of treatment for anemia in long term hemodialysis patients who have undergone frequent blood transfusions and iron therapy. Clinically, iron overload may be a serious problem for some maintenance hemodialysis patients and it may be manifested as organ dysfunctions. So, it is important to diagnose iron overload early and restrict blood transfusions and the administration of iron agents in these patients. We recently experienced one case of suspected primary hemochromatosis in a long term hemodialysis patient, and we evaluated the patient by checking the serum ferritin level and performing liver biopsy. Treatment with desferrioxamine was started with recombinant erythropoietin. We report on this case with a brief review of the literature.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Secondary hemochromatosis in a long term hemodialysis patients
- End-stage renal failure in 124 children: analysis of etiology, age and interal from early renal failure to the end stage
- Anemia and nutrition in end stage renal disease patient
- Clinical approach to quality of life in children with end-stage renal disease
- Acquired Cystic Kidney Disease in Patients Undergoing Long-term Hemodialysis Treatment
